Position in SEER
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$47,384
-$4,231 QoQ
Shares Held
28,205
0.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pathstone Holdings, LLC holds $81,066,919 across 49 Biotechnology names. SEER ranks #42 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
44,262 | $19,764,751 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,912 | $12,294,246 | |
| 3 | INSM |
INSMED Inc
|
27,249 | $4,455,756 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
28,252 | $2,977,760 | |
| 5 | CYTK |
Cytokinetics Inc
|
44,516 | $2,934,049 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
5,457 | $2,856,575 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
13,947 | $2,636,679 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
32,835 | $2,465,579 |
All Filings in SEER
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,384 | 28,205 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $51,615 | 28,205 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $61,204 | 28,205 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $117,090 | 54,715 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $95,332 | 56,410 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $65,153 | 28,205 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $55,563 | 28,205 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $44,536 | 26,510 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $50,369 | 26,510 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $51,429 | 26,510 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||